Disclosure Of Interests In Other Entities [Text Block]

ABIONYX Pharma - Filing #2821124

Concept 2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-01-01
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2019-01-01
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
10 033 EUR
10 125 EUR
Non-current assets
255,000 EUR
124,000 EUR
Current liabilities
3 598 EUR
3 466 EUR
Non-current liabilities
61,000 EUR
117,000 EUR
Revenue
0 EUR
0 EUR
Profit (loss)
1 886 EUR
1 886 EUR
1 849 EUR
1 849 EUR
Comprehensive income
1 891 EUR
1 849 EUR
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
9 154 EUR
8 331 EUR
8 331 EUR
11 457 EUR
Interest expense
0 EUR
0 EUR
Tax expense (income)
0 EUR
38,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.